Integrating CD4⁺ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model

Hirofumi Shibataa Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;b Department of Otolaryngology, Gifu University Graduate School of Medicine, Gifu, Japan

https://orcid.org/0000-0002-7104-9456 View further author information

Na Xua Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;c Department of Tea and Food Science, Anhui Agricultural University, Hefei, Anhui, PR ChinaView further author information

Shin Saitoa Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;d Department of Otolaryngology – Head and Neck Surgery, Keio University School of Medicine, Tokyo, JapanView further author information

Liye Zhoua Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information

Ibrahim Ozgenca Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information

Jason Webba Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information

Cong Fua Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information

Paul Zolkinde Department of Otolaryngology/ Head and Neck Surgery, Washington University, St. Louis, MO, USAView further author information

Ann Marie Egloffa Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;f Department of Surgery/Otolaryngology, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA, USAView further author information

Ravindra Uppaluria Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;f Department of Surgery/Otolaryngology, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]

https://orcid.org/0000-0001-5988-6828 View further author information

show all

Integrating CD4⁺ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Integrating CD4+ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Integrating CD4⁺ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model